ÂÜÀòÂÒÂ×

Galya Blachman is an accomplished legal professional specializing in biotechnology and life sciences, currently serving as Chief Legal Officer and Head of Business Development at Enliven Therapeutics since April 2020. Blachman also holds the position of Board Director and General Counsel at Biotech Connection - Bay Area, Inc. since June 2018. Previously, Blachman worked as a Legal Advisor at 5AM Ventures until December 2023 and served in various general counsel and compliance roles, including at AbbVie, Stemcentrx, Inc., and in prominent corporate law firms like Simmons & Simmons and Slaughter and May. Educational background includes a PhD in Pharmacology from the University of Cambridge and a Graduate Diploma in Intellectual Property Law from the University of Oxford, among other qualifications in law and sciences.